[go: up one dir, main page]

GB9203803D0 - A recombinant polypeptide - Google Patents

A recombinant polypeptide

Info

Publication number
GB9203803D0
GB9203803D0 GB929203803A GB9203803A GB9203803D0 GB 9203803 D0 GB9203803 D0 GB 9203803D0 GB 929203803 A GB929203803 A GB 929203803A GB 9203803 A GB9203803 A GB 9203803A GB 9203803 D0 GB9203803 D0 GB 9203803D0
Authority
GB
United Kingdom
Prior art keywords
recombinant polypeptide
polypeptide
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929203803A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB929203803A priority Critical patent/GB9203803D0/en
Publication of GB9203803D0 publication Critical patent/GB9203803D0/en
Priority to ZA931203A priority patent/ZA931203B/en
Priority to PCT/GB1993/000345 priority patent/WO1993017110A2/en
Priority to AU35096/93A priority patent/AU3509693A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB929203803A 1992-02-21 1992-02-21 A recombinant polypeptide Pending GB9203803D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB929203803A GB9203803D0 (en) 1992-02-21 1992-02-21 A recombinant polypeptide
ZA931203A ZA931203B (en) 1992-02-21 1993-02-19 A recombinant polypeptide
PCT/GB1993/000345 WO1993017110A2 (en) 1992-02-21 1993-02-19 A recombinant hepatitis c virus polypeptide
AU35096/93A AU3509693A (en) 1992-02-21 1993-02-19 A recombinant hepatitis C virus polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929203803A GB9203803D0 (en) 1992-02-21 1992-02-21 A recombinant polypeptide

Publications (1)

Publication Number Publication Date
GB9203803D0 true GB9203803D0 (en) 1992-04-08

Family

ID=10710857

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929203803A Pending GB9203803D0 (en) 1992-02-21 1992-02-21 A recombinant polypeptide

Country Status (4)

Country Link
AU (1) AU3509693A (en)
GB (1) GB9203803D0 (en)
WO (1) WO1993017110A2 (en)
ZA (1) ZA931203B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153378A (en) * 1992-10-16 2000-11-28 Bionova Corporation Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
KR100312535B1 (en) * 1993-04-30 2002-06-20 성재갑 Antibody Diagnosis of Hepatitis C Virus Using Mixed Antigens
WO1995011918A1 (en) * 1993-10-29 1995-05-04 Srl, Inc. Antigen peptide compound and immunoassay method
AU5924396A (en) * 1995-05-22 1996-12-11 Bionova Corporation Compositions and methods for the diagnosis of, and vaccinati on against, hepatitis c virus (hcv)
CA2485703A1 (en) 2002-05-24 2003-12-04 Fred W. Wagner Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
JP4636876B2 (en) 2002-05-24 2011-02-23 メドトロニック,インコーポレイテッド Methods and DNA constructs for high yield production of polypeptides
PT1704234E (en) 2003-11-21 2012-04-26 Nycomed Gmbh Production of glucagon like peptide 2 and analogs
MX2007004662A (en) 2004-10-18 2007-11-23 Globeimmune Inc Yeast-based therapeutic for chronic hepatitis c infection.
US8728489B2 (en) 2008-09-19 2014-05-20 Globeimmune, Inc. Immunotherapy for chronic hepatitis C virus infection
WO2010096115A1 (en) * 2008-10-29 2010-08-26 Apath, Llc Compounds, compositions and methods for control of hepatitis c viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002779A (en) * 1989-12-18 1991-07-16 Wellcome Found VIRAL AGENT.
CA2032907C (en) * 1989-12-22 2002-05-14 Richard R. Lesniewski Hepatitis c assay
BR9106309A (en) * 1990-04-04 1993-04-20 Chiron Corp COMBINATION OF SYNTHETIC ANTIGENS OF HEPATITIS C VIRAL (HCV), PROCESS OF DETECTING ANTIBODIES TO HEPATITIS C VIRUS AND CASE TO PERFORM TEST
CA2047792C (en) * 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
TW360711B (en) * 1991-06-10 1999-06-11 Lucky Ltd CDNAs of Korean hepatitis C virus and polypeptides encoded thereby

Also Published As

Publication number Publication date
WO1993017110A3 (en) 1993-10-14
ZA931203B (en) 1993-10-04
WO1993017110A2 (en) 1993-09-02
AU3509693A (en) 1993-09-13

Similar Documents

Publication Publication Date Title
GB2269176B (en) Peptides
ZA928511B (en) Peptides
GB9315303D0 (en) Polypeptide
ZA931203B (en) A recombinant polypeptide
IL106038A0 (en) Recombinant entomopoxvirus
GB9325519D0 (en) Peptides
ZA932648B (en) Sythetic polypeptides
AU4271793A (en) Novel polypeptide
GB8807427D0 (en) Peptides
GB9324013D0 (en) Polypeptides
GB8821077D0 (en) Peptides
ZW9093A1 (en) Synthetic polypeptides
PL299367A1 (en) Linear peptides
ZA931299B (en) Novel peptides
GB8828097D0 (en) Peptides
GB9106568D0 (en) Recombinant antigen
GB9226074D0 (en) Peptide
GB9218056D0 (en) Polypeptides
GB9213437D0 (en) Polypeptides
GB9210074D0 (en) Peptides
ZA935126B (en) Peptides
GB8826362D0 (en) Polypeptide
GB9309007D0 (en) Recombinant plasmid
ZA938572B (en) Improved recombinant protein production
GB9220010D0 (en) Recombinant virus